Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016 - Global Markets Direct - Market Research

Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016

Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016 - Global Markets Direct - Market Research
Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016
Published Jun 08, 2016
66 pages — Published Jun 08, 2016
Price US$ 2,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016, provides an overview of the Vasomotor Symptoms of Menopause (Hot Flashes) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Vasomotor Symptoms of Menopause (Hot Flashes), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Vasomotor Symptoms of Menopause (Hot Flashes) and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Vasomotor Symptoms of Menopause (Hot Flashes)
- The report reviews pipeline therapeutics for Vasomotor Symptoms of Menopause (Hot Flashes) by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Vasomotor Symptoms of Menopause (Hot Flashes) therapeutics and enlists all their major and minor projects
- The report assesses Vasomotor Symptoms of Menopause (Hot Flashes) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Vasomotor Symptoms of Menopause (Hot Flashes)

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Vasomotor Symptoms of Menopause (Hot Flashes)
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of le

  
Source:
Document ID
GMDHC8195IDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables51
  List of Figures51
Introduction61
  Global Markets Direct Report Coverage61
Vasomotor Symptoms of Menopause (Hot Flashes) Overview71
Therapeutics Development81
  Pipeline Products for Vasomotor Symptoms of Menopause (Hot Flashes) Overview81
Vasomotor Symptoms of Menopause (Hot Flashes) Therapeutics under Development by Companies91
Vasomotor Symptoms of Menopause (Hot Flashes) Pipeline Products Glance104
  Late Stage Products101
  Clinical Stage Products111
  Early Stage Products121
  Unknown Stage Products131
Vasomotor Symptoms of Menopause (Hot Flashes) Products under Development by Companies141
Vasomotor Symptoms of Menopause (Hot Flashes) Companies Involved in Therapeutics Development159
  Amgen Inc.151
  EndoCeutics, Inc.161
  Euroscreen S.A.171
  MenoGeniX, Inc.181
  Mithra Pharmaceuticals S.A.191
  Pherin Pharmaceuticals, Inc.201
  Pivot Pharmaceuticals Inc211
  Radius Health, Inc.221
  TherapeuticsMD, Inc.231
Vasomotor Symptoms of Menopause (Hot Flashes) Therapeutics Assessment2410
  Assessment by Monotherapy Products241
  Assessment by Combination Products251
  Assessment by Target262
  Assessment by Mechanism of Action282
  Assessment by Route of Administration302
  Assessment by Molecule Type322
Drug Profiles3422
  (acolbifene hydrochloride + prasterone) Drug Profile341
  (estradiol acetate + progesterone) Drug Profile352
  AMG-334 Drug Profile373
  ESN-364 Drug Profile402
  Estetrol Drug Profile422
  FP-101 Drug Profile441
  HBN-2 Drug Profile451
  homatropine methylbromide Drug Profile462
  MNGX-100 Drug Profile481
  PH-80HF Drug Profile491
  PVT-004 Drug Profile501
  Q-122 Drug Profile512
  RAD-1901 Drug Profile533
Vasomotor Symptoms of Menopause (Hot Flashes) Dormant Projects561
Vasomotor Symptoms of Menopause (Hot Flashes) Discontinued Products571
Vasomotor Symptoms of Menopause (Hot Flashes) Product Development Milestones587
  Featured News &Press Releases581
    Apr 01, 2016: Radius to provide an update on RAD1901 at the ENDO 2016 Annual Meeting581
    Oct 13, 2015: TherapeuticsMD Completes Enrollment in Phase 3 Clinical Trial of Bio-identical Oral Combination of Estradiol and Progesterone Product Candidate581
    Sep 23, 2015: Euroscreen launches Phase 2 clinical trial with ESN364 as the first and unique non-hormonal causal treatment for menopausal Hot Flashes591
    Jan 06, 2014: TherapeuticsMD Announces Milestone Achievement of 50th Site for Phase 3 Clinical Trial of TX 12-001HR to Treat Symptoms of Menopause and Provide Endometrial Protection591
    Oct 18, 2013: TherapeuticsMD Poster Wins First-Place Prize at the North American Menopause Society 2013 Annual Meeting591
    Sep 26, 2012: Eaton Scientific Highlights International Potential For Tropine 3 As Globally Accepted Non-Hormonal Treatment For Hot Flash Symptoms601
    Sep 25, 2012: Eaton Scientific Provides Outline On Market Potential Of Tropine 3 For Non-Hormonal Treatment Of Hot Flashes611
    Sep 13, 2012: Eaton Scientific Teams Up With Urologist Dr Jennifer Berman To Advance Tropine 3 Trials And Marketing611
    Sep 06, 2012: Eaton Scientific Completes Study Protocol For Phase I/II Study Of Tropine 3 For Treatment Of Hot Flashes611
    Sep 04, 2012: Eaton Scientific Enters Agreement With RoxSan Pharmacy To Provide Tropine 3 For Upcoming Clinical Trial Participants621
    Aug 28, 2012: Eaton Scientific Announces Clinical Trial Plans For Tropine 3 For Treatment Of Hot Flashes In Menopausal Women621
    Jun 19, 2010: Radius Presents Positive Phase IIa Study Results Of RAD1901 In Reducing Menopausal Hot Flashes631
    Jun 08, 2008: Radius Presents Preclinical Study Of RAD1901 At The Endocrine Society 2007 Annual Meeting641
Appendix652
  Methodology651
  Coverage651
  Secondary Research651
  Primary Research651
  Expert Panel Validation651
  Contact Us651
  Disclaimer661

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016" Jun 08, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Vasomotor-Symptoms-of-Menopause-Hot-Flashes-Pipeline-Review-H1-2016-2088-15923>
  
APA:
Global Markets Direct - Market Research. (2016). Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016 Jun 08, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Vasomotor-Symptoms-of-Menopause-Hot-Flashes-Pipeline-Review-H1-2016-2088-15923>
  
US$ 2,000.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.